Reasons for TKI Discontinuation ID ' d in Chronic Myeloid Leukemia

TUESDAY, April 16, 2019 -- For patients with chronic myeloid leukemia (CML), tyrosine kinase inhibitor (TKI) therapy can be safely discontinued and yields high rates of treatment-free remission (TFR), according to a study published online March 16...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news